Moses Cone Regional Cancer Center at Wesley Long Community Hospital — Greensboro, North Carolina

Moses Cone Regional Cancer Center at Wesley Long Community Hospital is a clinical research site located in Greensboro, North Carolina, United States 27403-1199.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Moses Cone Regional Cancer Center at Wesley Long Community Hospital has participated in 43 clinical trials with 2 currently active.

Therapeutic areas: Pancreatic Cancer, Breast Cancer, Breast Carcinoma.

Sponsors: SWOG Cancer Research Network, NSABP Foundation Inc, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moses Cone Regional Cancer Center at Wesley Long Community Hospital?

Moses Cone Regional Cancer Center at Wesley Long Community Hospital has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moses Cone Regional Cancer Center at Wesley Long Community Hospital conducted?

Moses Cone Regional Cancer Center at Wesley Long Community Hospital has 43 clinical trials on record, with 2 currently active. Their work covers Pancreatic Cancer, Breast Cancer, Breast Carcinoma.

Is Moses Cone Regional Cancer Center at Wesley Long Community Hospital accredited by Crixeo Health?

Moses Cone Regional Cancer Center at Wesley Long Community Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moses Cone Regional Cancer Center at Wesley Long Community Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.